Novartis has launched a new virtual innovation hub, Novartis Biome sub-Saharan Africa (SSA), for expediting digital health solutions in the region.
The hub will spearhead development of new solutions and business models to improve healthcare in the region.
Additionally, it will aim to create cross-sectoral partnerships to fast-track new approaches that would improve access to high-quality medicines and sustainably bolster health systems.
Novartis Biome SSA will primarily focus on extending affordable healthcare, strengthening early diagnosis for better results, innovation, and support HCP education and patient awareness.
By focusing on these four aspects, Novartis plans to double its patient reach in sub-Saharan Africa by next year, with an objective to increase to five-fold by 2025.
It will also continue its partnership with Medtronic Labs for providing care for patients with hypertension and diabetes.
Additionally, Novartis has partnered with the Commonwealth Pharmacists Association (CPA) to support training of more than one million pharmacists in all 54 Commonwealth countries.
With the launch of this hub in the sub-Saharan region, Novartis now has 11 innovation hubs across the globe.
Novartis sub-Saharan Africa president and head Racey Muchilwa said: “Our goal is to provide every patient in SSA with affordable access to high-quality medicines and to ultimately transform healthcare in the region.
“For this, innovation and digital technologies have an immense potential to contribute, and with cross-sectoral partnerships, we can truly maximise the impact on the health of our people.
“While healthcare innovation is at the core of our work at Novartis, we know that no single company can solve these challenges alone. Building strong partnerships and fostering greater collaboration is the only way to truly drive transformative, meaningful access improvements in our region.”